Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros

Base de datos
Tipo del documento
Intervalo de año
1.
Pol Przegl Chir ; 93(2): 43-52, 2021 Apr 27.
Artículo en Inglés | MEDLINE | ID: covidwho-1273648

RESUMEN

The current limitations of surgical treatment, as well as restrictions on professional and sport activities related to COVID-19 pandemic require seeking therapeutic solutions for the vast population of patients with chronic venous insufficiency (CVI, chronic venous insufficiency). To understand the principles of pharmacotherapy of this disease, the authors used data related to epidemiology and pathophysiology of CVI. They provided the latest data on venoactive drugs and recommendations that should be followed and summarized the literature based on the EBM. The article should provide the answer to the question of how to deal with patients with varicose veins or, more broadly, chronic venous insufficiency during the pandemic.


Asunto(s)
COVID-19/epidemiología , Tratamiento Conservador/estadística & datos numéricos , Insuficiencia Venosa/fisiopatología , Insuficiencia Venosa/terapia , Factores de Edad , Enfermedad Crónica , Humanos , Várices/fisiopatología , Várices/terapia , Insuficiencia Venosa/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA